Companies worldwide trust Springer Nature for high-quality databases that enhance decision-making and drive innovation. From drug data to protocols to materials science, our databases provide the compliant reference information you need. Discover tailored business and access models designed to meet your unique needs. Learn more about our flexible licensing options below. Contact us if you need more information.
AdisInsight
AdisInsight
Complete access to information about global drug development to identify opportunities, monitor competitors, and evaluate strengths and weaknesses allowing you to make more informed strategic decisions.
Ideal for: All organizations involved in developing prescription pharmaceuticals or interested in the organizations that do
Content: With over 550,000 profiles in a single platform, AdisInsight provides users the latest information on drug development, clinical trials, adverse events, patent expiry, and biopharma deals. Rights: Subscription, No continuing access
Access: IP-range provides seamless access for all users in the organizations or Username/Password access for named individuals. AdisInsight Start-up
Complete access to information about global drug development at special commercial terms to help emerging biopharma organizations make informed strategic decisions.
Ideal for: All biopharma organizations with series A, B, or C seed funding
Content: With over 550,000 profiles in a single platform, AdisInsight provides users the latest information on drug development, clinical trials, adverse events, patent expiry, and biopharma deals. Rights: Subscription, No continuing access
Access: Username/Password access for named individuals. AdisInsight Safety
Full access to a global biomedical reference database of validated Individual Case Safety Reports (ICSR) to improve the efficiency of ICSR literature monitoring.
Ideal for: All organizations with marketing authorization for prescription pharmaceuticals
Content: Over 266,000 summaries of validated Individual Case Safety Reports for adverse events and special situations sourced from global journals regardless of publisher. Rights: Subscription, No continuing access
Access: IP-range provides seamless access for all users in the organizations or Username/Password access for named individuals. AdisInsight Data Feed & API
Full access to information included in AdisInsight authored summaries of drug development programs and/or clinical trials to support integration or big data analysis.
Ideal for: All biopharma organizations pursuing data-driven drug research or aggregating information in an internal platform.
Content: Over 244,000 drug and trial profiles including phase of development linked to indication and location, drug properties and chemical synopsis, trial interventions, and trial outcomes. Rights: Subscription, No continuing access
Access: Username/Password access for named individuals. AdisInsight Timelines
Full access to key archive information included in AdisInsight authored summaries of drug development programs to assess trends and provide historical context.
Ideal for: All organizations pursuing data-driven drug research or aggregating information in an internal platform.
Content: Over 48,000 drug profiles including drug name and synonyms, phase of development linked to indication and location, mechanism of action, and originator and licensee organizations. Rights: Continuing access
Access: Username/Password access for named individuals.
SpringerMaterials
SpringerMaterials subscription
Complete access to the entire database including the prestigious Landolt-Börnstein book series, MSI Eureka, and SpringerMaterials Interactive
Ideal for: All research institutions aiming to increase research productivity in materials science
Content: With over 290,000 materials and 3,000+ properties in a single platform, SpringerMaterials provides consolidated, multisource data from all major topics in materials science, chemistry, physics, and engineering Rights: No archival rights
Access: Seamless and unlimited access to the entire database during the contract term via IP-Range or seat based model Archive
SpringerMaterials is pleased to offer two archival data sets: the complete Landolt-Börnstein book series - the most prestigious materials science book collection in the world, and the MSI Eureka database - a comprehensive collection of phase diagrams
Ideal for: Institutions looking to lower ongoing costs by adding valuable materials science data to their library
Content: Ownership of archived content up to, but not including the current copyright year Rights: Continuing access rights to archival content
Access: Access only to archival content of years purchased. No access to remaining parts of the platform Special note: Each archival purchase entitles the institution to a special discounted subscription price for access to the entire SpringerMaterials platform. Contact your local Springer Nature licensing representative today for your discounted subscription offer.
SpringerProtocols
SpringerProtocols access-only
Access to the largest collection of life science laboratory protocols searchable on Springer Nature Experiments and hosted on link.springer.com
Ideal for: Institutions aiming to increase research productivity and provide users with access to a vast amount of reliable, reproducible protocols
Content: Protocols content from well established book series: Methods in Molecular Biology, Methods in Molecular Medicine, Neuromethods, Methods in Pharmacology and Toxicology, Methods in Biotechnology, Springer Protocols Handbooks, and other Springer Protocols monographs Rights: Subscription rights to all copyright year
Access: Unlimited and seamless access only during the term Single year archives
Continuing access to Springer Protocols content from the current copyright year or previous standalone copyright years
Ideal for: Maximum flexibility and acquiring critical protocol archives
Content: Protocols content from well established book series: Methods in Molecular Biology, Methods in Molecular Medicine, Neuromethods, Methods in Pharmacology and Toxicology, Methods in Biotechnology, Springer Protocols Handbooks, and other Springer Protocols monographs Rights: Continuing access to current and/or individual copyright years
Access: Access to years purchased plus any other copyright years owned Full archive
Continuing access to Springer Protocols full archive covering content from 1980 through or previous copyright year
Ideal for: Institutions looking to minimize the number of resources to manage by investing in a stable, reliable collection with unparalleled breadth and depth of content
Content: Protocols from a variety of book series including Methods in Molecular Biology, Methods in Biotechnology, Methods in Molecular Medicine, Methods in Pharmacology and Toxicology, Neuromethods and Springer Protocols Handbooks Rights: Continuing access to copyright years 1980 - previous copyright year
Access: Continuing access to years purchased plus any other copyright years owned
Protocols.io
protocols.io access
With protocols.io you can choose an Industry Plan or Enterprise Solution that best suits your organization and research objectives. Click to learn more.
Terms and conditions apply
Flexible licensing and subscription options are available across all regions and markets, though some restrictions may apply based on your location. For more details, please contact your local representative.
Explore our access plans for
Stay up to date
